StreetAlpha
Puma Biotechnology, Inc. · SEC Form 4

PBYI Insider Trading

From SEC Form 429 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Puma Biotechnology, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $2.1M sold.

← PBYI stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$2.1M14 sales · 10 insiders
Net−$2.1Mbought minus sold
Planned sales94%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
Dec2026-01: sold $322KJanFebMarAprMay2026-06: sold $573KJun2026-07: sold $512KJulAug2026-09: sold $612KSepOct2026-11: sold $121KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when PBYI insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an PBYI officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every PBYI insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 11, 2026Michael Patrick MillerDirectorSale15,000$8.10$121K66,000Nov 13Form 4
Sep 14, 2026Alessandra CesanoDirectorSale plan62,150$9.12$567K56,700Sep 16Form 4
Sep 14, 2026Troy Edward WilsonDirectorSale plan5,000$9.10$46K54,750Sep 16Form 4
Jul 6, 2026Maximo F NouguesCFOSale plan9,386$8.26$78K230,637Jul 8Form 4
Jul 6, 2026Douglas M HuntSee RemarksSale plan8,460$8.26$70K196,841Jul 8Form 4
Jul 6, 2026Alan H AuerbachPresident and CEOSale plan44,058$8.26$364K7,261,671Jul 8Form 4
Jun 12, 2026Allison DorvalDirectorSale plan11,610$7.20$84K90,780Jun 15Form 4
Jun 12, 2026Jay M MoyesDirectorSale plan22,000$7.22$159K58,322Jun 15Form 4
Jun 12, 2026Adrian SenderowiczDirectorSale plan27,000$7.20$194K27,000Jun 15Form 4
Jun 12, 2026Brian M StuglikDirectorSale plan8,100$7.20$58K113,858Jun 15Form 4
Jun 12, 2026Troy Edward WilsonDirectorSale plan10,800$7.20$78K59,750Jun 15Form 4
Jan 7, 2026Maximo F NouguesCFOSale plan10,945$5.86$64K193,284Jan 8Form 4
Jan 7, 2026Douglas M HuntSee RemarksSale plan8,987$5.86$53K155,907Jan 8Form 4
Jan 7, 2026Alan H AuerbachPresident and CEOSale plan34,950$5.86$205K7,145,951Jan 8Form 4
Nov 11, 2025Michael Patrick MillerDirectorSale20,000$4.86$97K54,000Nov 13Form 4
🔒 14 more trades. Create a free account or sign in to see them all.

PBYI insider trading FAQ

Are PBYI insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of PBYI on the open market in 0 trades, and 10 sold $2.1M in 14 trades, 94% of that under pre-arranged trading plans.

When did an PBYI insider last buy shares?

There has been no open market insider purchase of PBYI in the last two years.

When did an PBYI insider last sell shares?

Michael Patrick Miller (Director) sold 15,000 shares for $121K on Nov 11, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice